[Breast scintigraphy with 99mTc-MIBI in the study of breast cancer].
BACKGROUND
The literature latest data point out the 99mTc-MIBI scintimammography role as a mammography diagnostic complement for a better nosologic definition of the breast nodular pathology. The object of this study is to evaluate the device sensibility and specificity with reference to the several dimensions of the neoplastic nodule.


METHODS
A group of 50 patients, with breast nodule has been studied comparing scintimammography, mammography, echography and istological examination of the removed nodule.


RESULTS
38 nodules out of 50 were carcinomas, 22 were T1 and 16 T2. As far as scintimammography is concerned, the sensibility is 86% in T1 grade and 100% in T2 grade. The specificity is 91.6%.


CONCLUSIONS
Since the mammography often need integration with invasive examinations, (aspiration biopsy, and biopsy) scintigraphy-mammography, global specificity 92%, is suggested as a second level examination in the mammary nodule diagnosis, for the simple performance and for the little risk for the patient.
Marzetti
L
L
Policlinico Umberto I, Università degli Studi di Roma La Sapienza, Roma.
Paolucci
A
A
Porfiri
L M
LM
De Vincentis
G
G
Ierardi
M
M
Tiberio
N S
NS
Scopinaro
F
F
D001706:Biopsy; D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D008327:Mammography / Q000379:methods*; D008403:Mass Screening; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi
D017256:Technetium Tc 99m Sestamibi
La scintigrafia mammaria con 99mTc-MIBI nello studio del carcinoma della mammella.